AI & ChatGPT searches , social queries for DOSTARLIMAB
Search references for DOSTARLIMAB. Phrases containing DOSTARLIMAB
See searches and references containing DOSTARLIMAB!
Search references for DOSTARLIMAB. Phrases containing DOSTARLIMAB
See searches and references containing DOSTARLIMAB!DOSTARLIMAB
Medication for endometrial cancer treatment
Dostarlimab, sold under the brand name Jemperli, is a monoclonal antibody used as an anti-cancer medication for the treatment of endometrial cancer. Dostarlimab
Dostarlimab
Class of anticancer drugs
CSCC who are not candidates for curative surgery or curative radiation. Dostarlimab (Jemperli) – was developed by GlaxoSmithKline and was first approved
PD-1_and_PD-L1_inhibitors
Cancer of the colon or rectum
stage II or III rectal adenocarcinoma were administered single-agent dostarlimab, an anti–PD-1 monoclonal antibody, every three weeks for six months.
Colorectal_cancer
British pharmaceutical and biotechnology company
the development and commercialisation of a subcutaneous formulation of dostarlimab, a programmed death receptor-1 (PD-1) blocking antibody. In February
GSK_plc
Anticancer medication
inhibitors PD-1 inhibitorsTooltip Programmed cell death protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip
Nivolumab
Medication
inhibitors PD-1 inhibitorsTooltip Programmed cell death protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip
Toripalimab
Pharmaceutical drug used in cancer treatment
inhibitors PD-1 inhibitorsTooltip Programmed cell death protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip
Pembrolizumab
Medication
inhibitors PD-1 inhibitorsTooltip Programmed cell death protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip
Retifanlimab
American pharmaceutical company
for breast and ovarian cancer. TSR-042 TSR-022 Dostarlimab – In February 2023, the FDA approved dostarlimab-gxly (Jemperli, GlaxoSmithKline LLC) for adults
Tesaro
Monoclonal antibody
Vatelizumab Vedolizumab Visilizumab Vobarilizumab TGN1412§ Immune activation: Dostarlimab Other: Ibalizumab Chimeric + humanized Otelixizumab Rozanolixizumab Sutimlimab
Theralizumab
Pharmaceutical compound
inhibitors PD-1 inhibitorsTooltip Programmed cell death protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip
CA-170
Combination medication
inhibitors PD-1 inhibitorsTooltip Programmed cell death protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip
Pembrolizumab/berahyaluronidase alfa
Pembrolizumab/berahyaluronidase_alfa
Pharmaceutical drug
inhibitors PD-1 inhibitorsTooltip Programmed cell death protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip
Durvalumab
Medication
inhibitors PD-1 inhibitorsTooltip Programmed cell death protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip
Nivolumab/hyaluronidase
Monoclonal anti-PD-L1 antibody
inhibitors PD-1 inhibitorsTooltip Programmed cell death protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip
Atezolizumab
Cipaglucosidase alfa To treat late-onset Pompe disease with miglustat Dabrafenib Dostarlimab Eflornithine Elranatamab To treat relapsed or refractory multiple myeloma
List of drugs granted breakthrough therapy designation
List_of_drugs_granted_breakthrough_therapy_designation
Uterine cancer that is located in tissues lining the uterus
hormone replacement therapy after treatment for endometrial cancer. Dostarlimab has been approved by the FDA for therapy of endometrial cancer with specific
Endometrial_cancer
(eptifibatide) (Europe) Jalyn (dutasteride-tamsulosin hydrochloride) Jemperli (dostarlimab) Jesduvroq (daprodustat) Lacipil (lacidipine) Lamictal (lamotrigine)
List_of_GSK_plc_products
Antibodies from clones of the same blood cell
approved by the FDA for cancer include: Alemtuzumab Bevacizumab Cetuximab Dostarlimab Gemtuzumab ozogamicin Ipilimumab Nivolumab Ofatumumab Panitumumab Pembrolizumab
Monoclonal_antibody
Pharmaceutical drug classification
Durvalumab L01FF04 Avelumab L01FF05 Atezolizumab L01FF06 Cemiplimab L01FF07 Dostarlimab L01FF08 Prolgolimab L01FF09 Tislelizumab L01FF10 Retifanlimab L01FF11
ATC_code_L01
Medication
Bermekimab Blinatumomab Cemiplimab Cosibelimab Daratumumab Dinutuximab beta Dostarlimab Durvalumab Elotuzumab Enfortumab vedotin Epcoritamab Inotuzumab ozogamicin
Elranatamab
Form of cancer immunotherapy
carcinoma, basal cell carcinoma, non-small cell lung cancer, cervical cancer Dostarlimab Jemperli Tesaro PD-1 2021 endometrial cancer Relatlimab Nivolumab Opdualag
Checkpoint_inhibitor
Monoclonal antibody
inhibitors PD-1 inhibitorsTooltip Programmed cell death protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip
Penpulimab
humanized Amyloid beta Y Alzheimer's disease Dorlimomab aritox F(ab')2 mouse Dostarlimab Jemperli mab humanized PCDP1 Y endometrial cancer Drozitumab mab human
List of therapeutic monoclonal antibodies
List_of_therapeutic_monoclonal_antibodies
Pharmaceutical drug
inhibitors PD-1 inhibitorsTooltip Programmed cell death protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip
Cemiplimab
Monoclonal antibody
Bermekimab Blinatumomab Cemiplimab Cosibelimab Daratumumab Dinutuximab beta Dostarlimab Durvalumab Elotuzumab Enfortumab vedotin Epcoritamab Inotuzumab ozogamicin
Mosunetuzumab
Cancer medication
inhibitors PD-1 inhibitorsTooltip Programmed cell death protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip
Avelumab
Medical condition
(ETTs) are resistant to chemotherapy, but an immunotherapy drug called dostarlimab treats gestational trophoblastic neoplasia. ETT is a form of GTN. Stage
Epithelioid trophoblastic tumour
Epithelioid_trophoblastic_tumour
Monoclonal antibody
Vatelizumab Vedolizumab Visilizumab Vobarilizumab TGN1412§ Immune activation: Dostarlimab Other: Ibalizumab Chimeric + humanized Otelixizumab Rozanolixizumab Sutimlimab
Spartalizumab
Anti-tumour drug
inhibitors PD-1 inhibitorsTooltip Programmed cell death protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip
BMS-202
DOSTARLIMAB
DOSTARLIMAB
DOSTARLIMAB
DOSTARLIMAB
Boy/Male
Indian, Punjabi, Sikh
Honourable; Modest
Surname or Lastname
English
English : patronymic from Kendrick 3.
Boy/Male
Tamil
A part of God
Boy/Male
English
Related to Avyan
Girl/Female
Indian, Punjabi, Sikh
Gratitude; Prayers
Boy/Male
Arabic
Duration; Endurance
Boy/Male
Spanish
Adventurous.
Boy/Male
Arabic, Hindu, Indian, Muslim
Mars
Surname or Lastname
English
English : variant spelling of Birks, itself a variant of Birch.
Surname or Lastname
English
English : variant spelling of Turpin.
DOSTARLIMAB
DOSTARLIMAB
DOSTARLIMAB
DOSTARLIMAB
DOSTARLIMAB